NUMMULAR ECZEMA

Clinical trials for NUMMULAR ECZEMA explained in plain language.

Never miss a new study

Get alerted when new NUMMULAR ECZEMA trials appear

Sign up with your email to follow new studies for NUMMULAR ECZEMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Hope for stubborn skin rash: existing drug tested for Hard-to-Treat eczema

Disease control Ongoing

This study is testing whether an existing medication called dupilumab (brand name Dupixent) can help people with nummular eczema, a chronic, itchy skin rash that is often difficult to treat. The trial will involve 70 adults with moderate-to-severe cases to see if the drug reduces…

Matched conditions: NUMMULAR ECZEMA

Phase: PHASE2 • Sponsor: Technical University of Munich • Aim: Disease control

Last updated Mar 09, 2026 14:26 UTC

NUMMULAR ECZEMA

Get alerted when new NUMMULAR ECZEMA trials appear

Hope for stubborn skin rash: existing drug tested for Hard-to-Treat eczema